Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)
China · Delayed Price · Currency is CNY 56.02
-0.83 (-1.46%)
Apr 17, 2026, 3:04 PM CST
SHE:002653 Revenue
In the year 2025, Haisco Pharmaceutical Group had annual revenue of 4.39B CNY with 17.91% growth. Haisco Pharmaceutical Group had revenue of 1.09B in the quarter ending December 31, 2025, with 12.12% growth.
Revenue
4.39B
Revenue Growth
+17.91%
P/S Ratio
14.16
Revenue / Employee
783.95K
Employees
5,597
Market Cap
62.14B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.39B | 666.44M | 17.91% |
| Dec 31, 2024 | 3.72B | 366.28M | 10.92% |
| Dec 31, 2023 | 3.36B | 339.78M | 11.27% |
| Jan 1, 2023 | 3.02B | 241.98M | 8.73% |
| Jan 1, 2022 | 2.77B | -556.28M | -16.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Revenue RankingsHaisco Pharmaceutical Group News
- 1 day ago - As China’s biotech firms shift gears, can AI floor the accelerator? - South China Morning Post